Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
2007 3
2008 7
2009 3
2010 7
2011 5
2012 7
2013 6
2014 8
2015 5
2016 5
2017 4
2018 3
2019 2
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Analysis of DNA methylation in cancer: location revisited.
Koch A, Joosten SC, Feng Z, de Ruijter TC, Draht MX, Melotte V, Smits KM, Veeck J, Herman JG, Van Neste L, Van Criekinge W, De Meyer T, van Engeland M. Koch A, et al. Among authors: van neste l. Nat Rev Clin Oncol. 2018 Jul;15(7):459-466. doi: 10.1038/s41571-018-0004-4. Nat Rev Clin Oncol. 2018. PMID: 29666440 Review.
Initial Findings from a High Genetic Risk Prostate Cancer Clinic.
Sessine MS, Das S, Park B, Salami SS, Kaffenberger SD, Kasputis A, Solorzano M, Luke M, Vince RA, Kaye DR, Borza T, Stoffel EM, Cobain E, Merajver SD, Jacobs MF, Milliron KJ, Caba L, van Neste L, Mondul AM, Morgan TM. Sessine MS, et al. Among authors: van neste l. Urology. 2021 Oct;156:96-103. doi: 10.1016/j.urology.2021.05.078. Epub 2021 Jul 17. Urology. 2021. PMID: 34280438
The epigenetic promise for prostate cancer diagnosis.
Van Neste L, Herman JG, Otto G, Bigley JW, Epstein JI, Van Criekinge W. Van Neste L, et al. Prostate. 2012 Aug 1;72(11):1248-61. doi: 10.1002/pros.22459. Epub 2011 Dec 7. Prostate. 2012. PMID: 22161815 Review.
Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers.
Joosten SC, Odeh SNO, Koch A, Buekers N, Aarts MJB, Baldewijns MMLL, Van Neste L, van Kuijk S, Schouten LJ, van den Brandt PA, Tjan-Heijnen VC, van Engeland M, Smits KM. Joosten SC, et al. Among authors: van neste l. Clin Epigenetics. 2021 May 4;13(1):103. doi: 10.1186/s13148-021-01084-8. Clin Epigenetics. 2021. PMID: 33947447 Free PMC article.
Epigenetic-based companion diagnostics.
Van Neste L, Jones GR, Van Criekinge W, Clark JS. Van Neste L, et al. Per Med. 2011 Nov;8(6):623-631. doi: 10.2217/pme.11.70. Per Med. 2011. PMID: 29776209
Epigenetic risk score improves prostate cancer risk assessment.
Van Neste L, Groskopf J, Grizzle WE, Adams GW, DeGuenther MS, Kolettis PN, Bryant JE, Kearney GP, Kearney MC, Van Criekinge W, Gaston SM. Van Neste L, et al. Prostate. 2017 Sep;77(12):1259-1264. doi: 10.1002/pros.23385. Epub 2017 Aug 1. Prostate. 2017. PMID: 28762545
Author Correction: Analysis of DNA methylation in cancer: location revisited.
Koch A, Joosten SC, Feng Z, de Ruijter TC, Draht MX, Melotte V, Smits KM, Veeck J, Herman JG, Van Neste L, Van Criekinge W, de Meyer T, van Engeland M. Koch A, et al. Among authors: van neste l. Nat Rev Clin Oncol. 2018 Jul;15(7):467. doi: 10.1038/s41571-018-0028-9. Nat Rev Clin Oncol. 2018. PMID: 29713045
60 results